Cullinan Therapeutics, Inc. (CGEM) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $448.37M | -27.9% |
| 2024 | $621.82M | +28.4% |
| 2023 | $484.18M | -13.7% |
| 2022 | $561.12M | +28.3% |
| 2021 | $437.19M | +103.6% |
| 2020 | $214.71M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $448.37M | -27.9% |
| 2024 | $621.82M | +28.4% |
| 2023 | $484.18M | -13.7% |
| 2022 | $561.12M | +28.3% |
| 2021 | $437.19M | +103.6% |
| 2020 | $214.71M | — |